Project to develop room-temperature storage for fragile biologics - Lab Canada labcanada.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labcanada.com Daily Mail and Mail on Sunday newspapers.
Intended Audience(s): Public Registration required. Fee required. Tickets required.
Lost In the Desert Sky will include all new music, and will be performed by Kahlor s ensemble, in remembrance of Shajarian. The film also introduces vocalist Hadi Hosseini, a former student of Shajarian s.
Across his career, Kalhor has composed music for Sajarian, and this film features all new pieces by him and tar player Ali Ashgar Arabshahi. The concert was filmed in the exquisite Mahinistan Raheb Hotel, a 200-year-old architecturally sublime historic locale in Kashan, an ancient desert city and an important stop on the Silk Road full of history.
E-Mail
Credit: McMaster University
Hamilton, ON (April 14, 2021) - Modified immune cells that ruthlessly kill cancerous tumours may prove a game-changer for people living with late-stage cancer.
McMaster University researchers Ali Ashkar and Sophie Poznanski have uncovered that changing the metabolism of natural killer (NK) immune cells allows these cells to overcome the hostile conditions found inside tumours and destroy advanced ovarian and lung cancer.
In the past decade cancer immunotherapy has achieved tremendous therapeutic effects in patient with blood cancers. However, the immunosuppressive conditions found inside solid tumours, whose aggressive growth starves surrounding healthy tissues of energy, have until now remained a formidable barrier for immune cell therapies.
Krebsforschung: Trainierte Immunzellen hochwirksam gegen Krebs heilpraxisnet.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heilpraxisnet.de Daily Mail and Mail on Sunday newspapers.
Novel immunotherapy combination can be highly effective for treating lung cancer
McMaster University researchers have established in lab settings that a novel combination of two forms of immunotherapy can be highly effective for treating lung cancer, which causes more deaths than any other form of cancer.
The new treatment, yet to be tested on patients, uses one form of therapy to kill a significant number of lung tumor cells, while triggering changes to the tumor that enable the second therapy to finish the job.
The first therapy employs suppressed natural killer immune cells by extracting them from patients tumors or blood and supercharging them for three weeks. The researchers condition the cells by expanding and activating them using tumor-like feeder cells to improve their effectiveness before sending them back into battle against notoriously challenging lung tumors.